XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Grant revenue $ 0 $ 1,268,829
Operating expenses:    
Research and development 4,439,475 1,740,655
General and administrative 1,677,754 1,332,769
Total operating expenses 6,117,229 3,073,424
Loss before other income (expense) (6,117,229) (1,804,595)
Change in fair value of warrant liability 5,808 (46,054)
Interest income (expense), net 2,196 (1,247)
Loss from continuing operations (6,109,225) (1,851,896)
Net loss $ (6,109,225) $ (1,851,896)
Loss per common share, basic ( in dollar per share) $ (0.13) $ (0.06)
Loss per common share, diluted ( in dollar per share) $ (0.13) $ (0.06)
Weighted average number of shares outstanding, basic (in shares) 46,255,210 30,551,316
Weighted average number of shares outstanding, diluted (in shares) 46,255,210 30,551,316
Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Grant [Member] Grant [Member]